Correlation Between Precision BioSciences and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and ZyVersa Therapeutics, you can compare the effects of market volatilities on Precision BioSciences and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and ZyVersa Therapeutics.
Diversification Opportunities for Precision BioSciences and ZyVersa Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Precision and ZyVersa is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Precision BioSciences and ZyVersa Therapeutics
Given the investment horizon of 90 days Precision BioSciences is expected to generate 0.53 times more return on investment than ZyVersa Therapeutics. However, Precision BioSciences is 1.89 times less risky than ZyVersa Therapeutics. It trades about -0.04 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 2,430 in Precision BioSciences on August 27, 2024 and sell it today you would lose (1,704) from holding Precision BioSciences or give up 70.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Precision BioSciences vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Precision BioSciences |
| ZyVersa Therapeutics |
Precision BioSciences and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and ZyVersa Therapeutics
The main advantage of trading using opposite Precision BioSciences and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Precision BioSciences vs. Eliem Therapeutics | Precision BioSciences vs. HCW Biologics | Precision BioSciences vs. Scpharmaceuticals | Precision BioSciences vs. Milestone Pharmaceuticals |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |